News

Enterome gets $41M for bowel disease, food allergy R&D | Health IT

By July 18, 2022No Comments

Nestle Health Science is investing $41 million private equity into biopharmaceutical company Enterome to research and develop drugs treating inflammatory bowel disease and food allergies.Health IT

Leave a Reply Cancel Reply

The Washington Metropolitan Area Chapter(WMAC) of the National Association of Health Services Executives (NAHSE) was chartered in 1978 to educate and develop minority healthcare leaders while, in conjunction with the American College of Healthcare Executives (ACHE), promoting C-Suite diversity for Healthcare Organizations throughout Northern Virginia, Southern Maryland, and the District of Columbia. The Washington Metropolitan Area Chapter (WMAC) was one of the first two chapters founded by the Association, since its inception.

Enterome gets $41M for bowel disease, food allergy R&D | Health IT

Tags:

Previous PostiPad stolen from Kaiser Permanente hospital had info of 75,000 patients | Health IT

Next Post$12K, free babysitting offered to lure tech workers from Silicon Valley | Health IT

Leave a Reply Cancel Reply

Join the NAHSE-WMAC Mailing List

Contact Us